Previous 10 | Next 10 |
2023-12-01 17:29:51 ET Gainers: Terns Pharmaceuticals ( TERN ) +10% . Alkermes ( ALKS ) +9% . Forrester Research ( FORR ) +7% . Amkor Technology ( AMKR ) +5% . LifeMD ( LFMD ) +4% . Losers: James River Group Holding...
2023-12-01 09:59:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Redhill Biopha...
Finch Therapeutics Group Inc. (FNCH) is expected to report for Q3 2023
2023-06-13 10:10:06 ET Gainers: First Wave BioPharma ( FWBI ) +150% . YS Biopharma ( YS ) +20% . Akoya Biosciences ( AKYA ) +17% . Evoke Pharma ( EVOK ) +16% . Surmodics ( SRDX ) +16% . Losers: Jin Medical International ( ...
2023-06-13 08:20:35 ET Auddia ( AUUD ) -37% . Advanced Health Intelligence ( AHI ) -28% . Finch Therapeutics Group ( FNCH ) -22% . Asset Entities ( ASST ) -18% . Jin Medical International Ltd. ( ZJYL ) -16% on releasing new-generatio...
2023-06-12 17:14:04 ET Gainers: ARS Pharmaceuticals ( NASDAQ: SPRY ) +5% . Mersana Therapeutics ( MRSN ) +4% . Frontier Group ( ULCC ) +2% . Sterling Infrastructure ( STRL ) +2% . Stitch Fix ( SFIX ) +2% . Losers:...
2023-06-09 07:11:38 ET Finch Therapeutics ( NASDAQ: FNCH ) will effect a one-for-30 reverse stock split of its issued and outstanding common stock, effective opening of trading on June 12, The reverse stock split is intended to increase the per share trading price of Finch...
BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced it w...
2023-05-10 13:37:04 ET Finch Therapeutics press release ( NASDAQ: FNCH ): Q1 GAAP EPS of -$1.33 misses by $1.24 . Revenue of $0.11M (-68.6% Y/Y). For further details see: Finch Therapeutics GAAP EPS of -$1.33 misses by $1.24, revenue of $0.11M
SOMERVILLE, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today repo...
News, Short Squeeze, Breakout and More Instantly...
Finch Therapeutics Group Inc. Company Name:
FNCH Stock Symbol:
NASDAQ Market:
Finch Therapeutics Group Inc. Website:
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 8.6% to $0.0384 on volume of 89,961,220 shares Nuburu Inc. (BURU) rose 29.4% to $0.207 on volume of 85,213,370 shares Novo Integrated Sciences Inc. (NVOS) rose 139.5% to $1.08 on volume ...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 5.3% to $0.0839 on volume of 148,968,464 shares Netcapital Inc. (NCPL) rose 66.0% to $0.2901 on volume of 111,713,040 shares Cue Health Inc. (HLTH) rose 33.6% to $0.126 on volume of 99,7...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...